arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1611.04660cs.AIstat.AP
收藏

观察数据中的因果推断

Causal Inference in Observational Data

University of Minnesota(明尼苏达大学);Mayo Clinic(梅奥诊所)

Pranjul Yadav, Lisiane Prunelli, Alexander Hoff, Michael Steinbach, Bonnie Westra, Vipin Kumar, Gyorgy Simon

摘要:

我们的老龄化人口越来越多地同时患有多种慢性疾病,需要对这些疾病进行综合治疗。为一组组合疾病寻找最优药物组是一个组合模式探索问题。关联规则挖掘是一种流行的工具,这样的问题,但医疗保健的需求,寻找因果关系,而不是关联,模式使得关联规则挖掘不适合。为了解决这个问题,我们提出了一个新的框架的基础上Rubin-Neyman因果模型从观测数据中提取因果规则,纠正一些常见的偏见。具体地说,给定一组干预措施和一组定义亚群的项目(例如,疾病),我们希望找到其中存在有效干预组合的所有亚群,并且在每个这样的亚群中,我们希望找到所有干预组合,使得从该组合中丢弃任何干预将降低治疗的功效。我们的框架的一个关键方面是封闭的干预集的概念,它扩展了量化单个干预的效果的概念,一组并发的干预。我们还评估了我们的因果规则挖掘框架的电子健康记录(EHR)数据的一个大队列的患者从梅奥诊所,并表明,我们提取的模式是足够丰富的解释有争议的发现在医学文献中的一类胆固醇药物对II型糖尿病(T2 DM)的影响。

英文摘要:

Our aging population increasingly suffers from multiple chronic diseases simultaneously, necessitating the comprehensive treatment of these conditions. Finding the optimal set of drugs for a combinatorial set of diseases is a combinatorial pattern exploration problem. Association rule mining is a popular tool for such problems, but the requirement of health care for finding causal, rather than associative, patterns renders association rule mining unsuitable. To address this issue, we propose a novel framework based on the Rubin-Neyman causal model for extracting causal rules from observational data, correcting for a number of common biases. Specifically, given a set of interventions and a set of items that define subpopulations (e.g., diseases), we wish to find all subpopulations in which effective intervention combinations exist and in each such subpopulation, we wish to find all intervention combinations such that dropping any intervention from this combination will reduce the efficacy of the treatment. A key aspect of our framework is the concept of closed intervention sets which extend the concept of quantifying the effect of a single intervention to a set of concurrent interventions. We also evaluated our causal rule mining framework on the Electronic Health Records (EHR) data of a large cohort of patients from Mayo Clinic and showed that the patterns we extracted are sufficiently rich to explain the controversial findings in the medical literature regarding the effect of a class of cholesterol drugs on Type-II Diabetes Mellitus (T2DM).

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑